Home About Login Current Archives Announcements Editorial Board
Submit Now For Authors Call for Submissions Statistics Contact
Home > Archives > Volume 20, No 8 (2022) > Article

DOI: 10.14704/nq.2022.20.8.NQ44453

Cabergoline

Mohammed Rabie Osman Mahdy1*, AmgadOsman Gohar2,Hashem Fares Mohammed3,Alaa GamalAbd Al Azeem4, Mohamed Ahmed Ahmed5

Abstract

The syndrome nearly always presents either up to eight days once human chorionic gonadotrophin administration in vulnerable patients (early onset) or throughout early physiological state, nine or additional days once human chorionic gonadotrophin administration associated with physiological state evoked human chorionic gonadotrophin production.

Keywords

Treating Modalities, Cavum and Lungs, Gonadotrophin Injection.

Full Text

PDF

References

?>